← back to database
Omega Funds creates and invests in life-science companies across multiple therapeutic areas, including oncology, immunology, rare disease, and precision medicine. It invests from company formation and early stage through later and pre-IPO rounds, and can lead or co-lead large financings.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$470.0M Fund VIII
Investing team
- Bernard DavitianInvestor
- Claudio NessiInvestor
- Deirdre CunnaneInvestor
- Eric CooperInvestor
- Francesco DraettaManaging Director
- Kurt Kongtong-GallagherInvestor
- Michelle DoigInvestor
- Noelle HutchinsInvestor
- Otello StampacchiaInvestor
- Saoussen Ben HalimaInvestor
- Vincent OssipowInvestor